Author

Kazuko Nagase

Observed names: K Nagase, K. Nagase

Observed institution: Hyogo Medical University

ORCID: 0000-0002-7285-9020

Observed ORCID: 0000-0002-7285-9020

OpenAlex ID: A5055543728

Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

2011 · Koji Yoshida, Ken Fukunaga, et al. · Inflammatory Bowel Diseases · 154

PDF

Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by Erythrocytes

1994 · Kazuko Nagase, Kazuhide Iwasaki, et al. · Journal of Pharmacy and Pharmacology · 118

The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease

2009 · K Kamikozuru, K Fukunaga, et al. · Clinical & Experimental Immunology · 43

Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis

2012 · Ken Fukunaga, Yoshio Ohda, et al. · Journal of Gastroenterology and Hepatology · 42

Complications of Leukocytapheresis

1998 · Kazuko Nagase, Koji Sawada, et al. · Therapeutic Apheresis and Dialysis · 38

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA

2013 · Yoko Yokoyama, Mikio Kawai, et al. · BMC Gastroenterology · 32

PDF

Adsorptive Granulocyte/Monocyte Apheresis for the Maintenance of Remission in Patients with Ulcerative Colitis: A Prospective Randomized, Double Blind, Sham-Controlled Clinical Trial

2012 · Ken Fukunaga, Yoko Yokoyama, et al. · Gut and Liver · 27

The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy

2011 · Yoko Yokoyama, Ken Fukunaga, et al. · Cytokine · 26

Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease

2010 · Ken Fukunaga, Yoko Yokoyama, et al. · Journal of Clinical Apheresis · 25

PDF

Xilei San Ameliorates Experimental Colitis in Rats by Selectively Degrading Proinflammatory Mediators and Promoting Mucosal Repair

2014 · Yongbiao Hao, Kazuko Nagase, et al. · Evidence-based Complementary and Alternative Medicine · 18

PDF

A Suppository Chinese Medicine (Xilei-san) for Refractory Ulcerative Proctitis: A Pilot Clinical Trial

2007 · Ken Fukunaga, Nobuyuki Hida, et al. · Digestion · 17

PDF

Evaluation of discomfort during colonoscopy with conventional and ultrathin colonoscopes in ulcerative colitis patients

2014 · Tomohiro Ogawa, Yoshio Ohda, et al. · Digestive Endoscopy · 16

Detection of Specific IgE Antibodies to Nafamostat Mesilate as an Indication of Possible Adverse Effects of Leukocytapheresis using Nafamostat Mesilate as Anticoagulant

2004 · Kazuko Nagase, Ken Fukunaga, et al. · Therapeutic Apheresis and Dialysis · 16

PDF

Immunoregulatory Effects of Adsorptive Granulocyte and Monocyte Apheresis in Patients with Drug Refractory Crohn's Disease

2011 · Kazuko Nagase, Ken Fukunaga, et al. · Therapeutic Apheresis and Dialysis · 14

Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure

2023 · Toshiyuki Sato, Motoi Uchino, et al. · Clinical Nutrition · 12

Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profile

2014 · Yoko Yokoyama, Ken Fukunaga, et al. · Cytotherapy · 8

Relevance of the Processed Blood Volume per Granulocyte and Monocyte Apheresis Session to its Clinical Efficacy in Patients With Ulcerative Colitis

2011 · Risa Kikuyama, Ken Fukunaga, et al. · Therapeutic Apheresis and Dialysis · 7

Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with cellsorba in patients with active ulcerative colitis

2011 · Ken Fukunaga, Koji Kamikozuru, et al. · Journal of Clinical Apheresis · 5

Granulocyte and Monocyte Adsorptive Apheresis for Patients with Chronic Hepatitis C Virus Infection: A Report on Six Cases with High Plasma Viremia

2003 · Koji Sawada, Kunio Ohnishi, et al. · Therapeutic Apheresis and Dialysis · 5

[Leukocytapheresis for ulcerative colitis].

1999 · K Fukunaga, K Sawada, et al. · PubMed · 5

DOP24 Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim analyses of the J-COMBAT trial

2022 · K Watanabe, T Hisamatsu, et al. · Journal of Crohn s and Colitis · 4

Questionnaire Based Assessment of Patients' Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease

2013 · Kazuko Nagase, Ken Fukuanga, et al. · Therapeutic Apheresis and Dialysis · 4

Cytapheresis in Patients with Severe Ulcerative Colitis after Failure of Intravenous Corticosteroid: A Long-Term Retrospective Cohort Study

2009 · Ken Fukunaga, Kazuko Nagase, et al. · Gut and Liver · 4

Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: Relevance to extracorporeal immunomodulation

2008 · Katsuyuki Tozawa, Ken Fukunaga, et al. · Transfusion and Apheresis Science · 4

Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium

2023 · Serre-Yu Wong, Judith Wellens, et al. · Inflammatory Bowel Diseases · 3

PDF

Works count: 37

Citation count: 647

H-index: 14

I10-index: 15